While TRIM44 expression in MM cells increases bone destruction in xenograft mice, mirroring observations in MM patients [15], the mechanisms by which TRIM44 contributes to drug resistance in MM remain unclear. The gene discussed is TRIM44; the disease is Miyoshi myopathy.